4
Changes in Ownership
Medicus Pharma Ltd. Filed Acc 0000950142-26-001033
Options or other derivatives
- Chief Operating Officer acquired 50,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Smith Andrew Alasdair Chief Operating Officer | 2026-03-30 | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | D | ||
Loading xslF345X06/es260758781_4-smitha.xml…